Direct and GTP-dependent interaction of ADP-ribosylation factor 1 with clathrin adaptor protein AP-1 on immature secretory granules.

ADP-ribosylation factor 1 (ARF1) mediates clathrin coat formation on PC12 immature secretory granules (ISGs). We have used two approaches to investigate whether ARF1 interacts directly with the clathrin adaptor protein, AP-1. Using an in vitro recruitment assay and co-immunoprecipitation, we could isolate an AP-1.ARF1 complex. Then we used a site-directed photocross-linking approach to determine the components that act downstream of ARF1 in clathrin coat formation on ISGs. Myristoylated ARF1, with a photolabile phenylalanine analogue incorporated into its putative effector domain (switch 1), showed a specific, GTP-dependent interaction with both the gamma- and beta-adaptin subunits of AP-1 on ISGs. These experiments provide evidence for a direct interaction of ARF1 with AP-1. On mature secretory granules myristoylated ARF1 does not bind, and hence clathrin coat formation cannot be initiated, supporting the hypothesis that molecules involved in coat recruitment are removed during ISG maturation.

The orientation of membrane proteins determined in situ by immunofluorescence staining.

Structural and functional characterization of membrane proteins includes the determination of their orientation within the membrane (integral proteins), or their exposure at either the cytosolic or extracytoplasmic surface of the membrane (peripheral proteins). We have developed an easily handled immunofluorescence-based method to investigate the exposure of antigenic epitopes at either surface of the membranes in situ. We present conditions for permeabilization of p-formaldehyde-fixed cells which allow the discrimination of epitopes exposed either at the cytosolic face of membranes, within the lumen of vesicles, or at the cell surface. The potential applications of this method include (1) the use of domain-specific antibodies as a tool to study integral membrane proteins with regard to the orientation of their carboxy-terminal and amino-terminal ends or the orientation of the loops of multispanning proteins, and (2) the assignment of the epitope of monoclonal antibodies to the cytosolic or luminal domain of integral membrane proteins with the established structure.